Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists (Q41387206)

30 September 2017

Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists (English)

1 reference

30 September 2017

1 reference

M Davis

1

1 reference

30 September 2017

1 January 1987

1 reference

30 September 2017

1 reference

30 September 2017

93

1 reference

30 September 2017

3

1 reference

30 September 2017

286-291

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00187244

30 September 2017

0 references

cites work

Effects of 6-hydroxydopamine lesions of locus coeruleus on startle in rats.

1 reference

12 December 2020

Mescaline increases startle responding equally in normal and raphe-lesioned rats

1 reference

12 December 2020

Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli

1 reference

12 December 2020

Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline

1 reference

12 December 2020

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

1 reference

12 December 2020

Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input

1 reference

12 December 2020

Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.

1 reference

12 December 2020

Mechanistic studies on DOM as a discriminative stimulus

1 reference

12 December 2020

Blockade of the stimulus properties of mescaline by a serotonin antagonist

1 reference

12 December 2020

Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus

1 reference

12 December 2020

Habituation of startle response under incremental sequence of stimulus intensities

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

1 reference

12 December 2020

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists

1 reference

12 December 2020

Spinal modulation of the acoustic startle response: the role of norepinephrine, serotonin and dopamine

1 reference

12 December 2020

Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain

1 reference

12 December 2020

Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow

1 reference

12 December 2020

Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.

1 reference

12 December 2020

Dissociations between the effects of LSD on behavior and raphe unit activity in freely moving cats

1 reference

12 December 2020

Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.

1 reference

12 December 2020

Serotonergic facilitation of facial motoneuron excitation

1 reference

12 December 2020

The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents

1 reference

12 December 2020

Effects of lysergic acid diethylamide (LSD) on habituation and sensitization of the startle response in the rat.

1 reference

12 December 2020

paraChlorophenylalanine potentiates facilitatory effects of mescaline on shuttlebox escape/avoidance in rats

1 reference

12 December 2020

Involvement of 5-HT2 receptors in the LSD- and L-5-HTP-induced suppression of lordotic behavior in the female rat

1 reference

12 December 2020

A primary acoustic startle circuit: lesion and stimulation studies.

1 reference

12 December 2020

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

12 December 2020

Excitatory and inhibitory effects of serotonin on sensorimotor reactivity measured with acoustic startle

1 reference

12 December 2020

Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine

1 reference

12 December 2020

The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.

1 reference

12 December 2020

The design and calibration of a startle measurement system

1 reference

12 December 2020

Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats

1 reference

12 December 2020

LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat

1 reference

12 December 2020

Response of central monoaminergic neurons to lisuride: Comparison with LSD

1 reference

12 December 2020

Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats

1 reference

12 December 2020

Lysergic Acid Diethylamide: Sensitive Neuronal Units in the Midbrain Raphe

1 reference

12 December 2020

In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.

1 reference

12 December 2020

Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine

1 reference

12 December 2020

Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input

1 reference

12 December 2020

Central noradrenergic involvement in yohimbine excitation of acoustic startle: effects of DSP4 and 6-OHDA.

1 reference

12 December 2020

Clinical reactions and tolerance to LSD in chronic schizophrenia

1 reference

12 December 2020

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

1 reference

12 December 2020

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

1 reference

12 December 2020

DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.

1 reference

12 December 2020

Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.

1 reference

12 December 2020

5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

1 reference

12 December 2020

Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat

1 reference

12 December 2020

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

1 reference

12 December 2020

The discriminative stimulus properties of LSD: mechanisms of action

1 reference

12 December 2020

Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148

1 reference

12 December 2020

Effects of LSD-25 on brain serotonin.

1 reference

12 December 2020

Role of serotonin in the discriminative stimulus properties of mescaline

1 reference

12 December 2020

Behavior and binding: Correlations between α1-adrenergic stimulation of acoustic startle and α1-adrenoceptor occupancy and number in rat lumbar spinal cord

1 reference

12 December 2020

Lysergic acid diethylamide and serotonin: Direct actions on serotonin-containing neurons in rat brain

1 reference

12 December 2020

Mescaline and LSD: Direct and indirect effects on serotonin-containing neurons in brain

1 reference

12 December 2020

Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding.

1 reference

12 December 2020

The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle

1 reference

12 December 2020

Serotonin receptor subtype agonists: differential effects on sensorimotor reactivity measured with acoustic startle.

1 reference

12 December 2020

Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors

1 reference

12 December 2020

Biphasic dose-response effects of N-N-dimethyltryptamine on the rat startle reflex

1 reference

12 December 2020

Acute and chronic LSD effects on rat startle: data supporting an LSD--rat model of schizophrenia.

1 reference

12 December 2020

Mode of action of LSD on serotonergic neurons.

1 reference

12 December 2020

Effects of d- and l-amphetamine on habituation and sensitization of the acoustic startle response in rats

1 reference

12 December 2020

Action of psychotogenic drugs on single midbrain raphe neurons

1 reference

12 December 2020

A characterization of LSD-antagonist effects of pirenperone in the rat.

1 reference

12 December 2020

Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.

1 reference

12 December 2020

Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine.

1 reference

12 December 2020

Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.

1 reference

12 December 2020

5-Methoxy-N,N-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle

1 reference

12 December 2020

Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity.

1 reference

12 December 2020

Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide

1 reference

12 December 2020

[Effects of lysergic acid amide 25 on the startle reaction in the rat]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00187244

1 reference

PubMed ID

3124159

Dimensions Publication ID

30 September 2017

1050533675

0 references

Fatcat ID

release_tfsa5b6cpfbz7ifwmczpjev7qq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tfsa5b6cpfbz7ifwmczpjev7qq

24 November 2022

mapped directly with Wikidata item

PubMed ID

3124159

1 reference

PubMed ID

3124159